Study of Ravulizumab in Immunoglobulin A Nephropathy (IgAN)
Clinical trial NCT06291376 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06291376
- Sponsor
- Alexion Pharmaceuticals, Inc.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-03-29
- Primary completion
- 2026-01-05
- Enrollment
- 579
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.